Guerbet S. A. Cash Flow Conversion Efficiency
Guerbet S. A. cash flow conversion efficiency. Based on the latest financial reports, Guerbet S. A. (GBT) has a cash flow conversion efficiency ratio of 0.188x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€48.81 Million ≈ $57.07 Million USD) by net assets (€260.08 Million ≈ $304.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guerbet S. A. (2004–2025)
Cash flow conversion efficiency of Guerbet S. A. from 2004 to 2025. This chart illustrates how Guerbet S. A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Guerbet S. A. for real-time trading data and today's change.
Guerbet S. A. Cash Flow Conversion Ratio Explained
Guerbet S. A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guerbet S. A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guerbet S. A. ranked by their cash flow conversion efficiency. Also see Guerbet S. A. market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shinsegae Food
KO:031440
|
-0.062x |
|
Papoutsanis S.A
AT:PAP
|
0.086x |
|
United Recommend International Co Ltd
TWO:5321
|
0.167x |
|
NextEye Co. Ltd
KQ:137940
|
-0.144x |
|
Jung Shing Wire Co Ltd
TW:1617
|
-0.018x |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
4.726x |
|
Cemacon Zalau
RO:CEON
|
N/A |
|
Negri Sembilan Oil Palms Bhd
KLSE:2038
|
0.008x |
Annual Cash Flow Conversion Efficiency for Guerbet S. A. (2004–2025)
The table below shows the annual cash flow conversion efficiency of Guerbet S. A. from 2004 to 2025. Review Guerbet S. A. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €260.08 Million ≈ $304.06 Million |
€61.29 Million ≈ $71.66 Million |
0.236x | +13.62% |
| 2024-12-31 | €391.57 Million ≈ $457.79 Million |
€81.22 Million ≈ $94.95 Million |
0.207x | +185.97% |
| 2023-12-31 | €378.27 Million ≈ $442.24 Million |
€27.44 Million ≈ $32.08 Million |
0.073x | -9.56% |
| 2022-12-31 | €379.57 Million ≈ $443.76 Million |
€30.44 Million ≈ $35.59 Million |
0.080x | -71.99% |
| 2021-12-31 | €405.09 Million ≈ $473.60 Million |
€115.97 Million ≈ $135.58 Million |
0.286x | -12.58% |
| 2020-12-31 | €367.75 Million ≈ $429.94 Million |
€120.43 Million ≈ $140.80 Million |
0.327x | -2.91% |
| 2019-12-31 | €389.19 Million ≈ $455.01 Million |
€131.27 Million ≈ $153.47 Million |
0.337x | +60.82% |
| 2018-12-31 | €366.76 Million ≈ $428.78 Million |
€76.92 Million ≈ $89.93 Million |
0.210x | +28.02% |
| 2017-12-31 | €342.14 Million ≈ $400.00 Million |
€56.05 Million ≈ $65.53 Million |
0.164x | +33.31% |
| 2016-12-31 | €314.80 Million ≈ $368.03 Million |
€38.69 Million ≈ $45.23 Million |
0.123x | -47.13% |
| 2015-12-31 | €282.44 Million ≈ $330.20 Million |
€65.65 Million ≈ $76.75 Million |
0.232x | +0.42% |
| 2014-12-31 | €259.10 Million ≈ $302.92 Million |
€59.98 Million ≈ $70.12 Million |
0.231x | -6.97% |
| 2013-12-31 | €238.26 Million ≈ $278.55 Million |
€59.28 Million ≈ $69.30 Million |
0.249x | +26.10% |
| 2012-12-31 | €226.21 Million ≈ $264.46 Million |
€44.63 Million ≈ $52.18 Million |
0.197x | +2.26% |
| 2011-12-31 | €214.80 Million ≈ $251.12 Million |
€41.44 Million ≈ $48.45 Million |
0.193x | +9.66% |
| 2010-12-31 | €210.52 Million ≈ $246.12 Million |
€37.04 Million ≈ $43.30 Million |
0.176x | -2.95% |
| 2009-12-31 | €205.31 Million ≈ $240.02 Million |
€37.22 Million ≈ $43.51 Million |
0.181x | +6.39% |
| 2008-12-31 | €185.73 Million ≈ $217.13 Million |
€31.65 Million ≈ $37.00 Million |
0.170x | -27.70% |
| 2007-12-31 | €170.96 Million ≈ $199.86 Million |
€40.29 Million ≈ $47.11 Million |
0.236x | +244.21% |
| 2006-12-31 | €152.14 Million ≈ $177.86 Million |
€10.42 Million ≈ $12.18 Million |
0.068x | -76.90% |
| 2005-12-31 | €141.16 Million ≈ $165.03 Million |
€41.84 Million ≈ $48.92 Million |
0.296x | +10.90% |
| 2004-12-31 | €120.21 Million ≈ $140.54 Million |
€32.13 Million ≈ $37.56 Million |
0.267x | -- |
About Guerbet S. A.
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more